目的 比较高海拔地区硬通道穿刺引流与非手术治疗基底节区中小量高血压性脑出血的疗效。方法 选取2015-01至2020-12武警青海总队医院收治的高血压性脑出血患者80例,出血部位均为基底节区,出血量20~40 ml,按随机数字表法分为两组:硬通道穿刺引流术为观察组,非手术治疗为对照组,分析比较两组治疗后语言障碍、肢体功能障碍等后遗症,比较美国国立卫生卒中量表(NIHSS)和日常生活能力评定(Barthel Index,BI)评分。结果 治疗3周后,观察组与对照组语言障碍发生率分别为2.5%和25.0%,肢体功能障碍发生率分别为5.0%和27.5%,两组比较差异有统计学意义(均P<0.01)。治疗3周后,观察组NIHSS评分(12.08±4.28)明显低于对照组(16.50±6.60),BI评分(29.33±8.46)高于对照组(20.48±6.47),差异有统计学意义(均P<0.01)。结论 高海拔地区应用硬通道穿刺引流治疗基底节区中小量高血压性脑出血的临床疗效优于非手术治疗。
Abstract
Objective To explore the clinical efficacy of hard channel puncture and drainage and conservative treatment of small and medium hypertensive cerebral hemorrhage in basal ganglia on high altitude areas. Methods Eighty patients of hypertensive cerebral hemorrhage (20-40 ml) in basal ganglia admitted to our hospital from January 2015 to December 2020 were randomly divided into two groups: the observation group (hard channel puncture drainage) and the control group (internal conservative treatment). The sequelae of language impairment, limb dysfunction, NIHSS score, and Barthel Index (BI) score were analyzed and compared respectively. Results After 3 weeks of therapy, the incidence of language impairment of the observation and control group were 2.5% and 25.0%, the incidence of limb dysfunction of both groups were 5.0% and 27.5%, respectively, and the differences were statistically significant (P<0.01). The NIHSS of the observation group (12.08±4.28) was significantly lower than that of the control group (16.50±6.60) after 3 weeks therapy (P<0.01), and the Barthel Index of the observation group (29.33±8.46) was better than that of the control group (20.48±6.47, P<0.01). Conclusions The treatment of hard channel puncture and drainage is better than the conservative treatment of hypertensive cerebral hemorrhage in basal ganglia on high altitude areas.
关键词
高血压脑出血 /
非手术治疗 /
硬通道穿刺引流 /
临床疗效
Key words
hypertensive cerebral hemorrhage /
conservative treatment /
hard channel puncture and drainage /
clinical efficacy
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Hostettler I C, Seiffge D J, Werring D J. Intracerebral hemorrhage: an update on diagnosis and treatment [J]. Expert Rev Neurother, 2019, 19(7): 679-694.
[2] Robles L A, Volovici V. Hypertensive primary intraventricular hemorrhage: a systematic review [J]. Neurosurg Rev, 2022, 45(3): 2013-2026.
[3] 张 彬, 马京库. 高血压脑出血钻孔引流术后预后影响因素分析[J]. 陕西医学杂志, 2022, 51(4): 470-473.
[4] Oliveira Manoel A L. Surgery for spontaneous intracerebral hemorrhage [J]. Crit Care, 2020, 24(1): 45.
[5] Xu S Y, Pang Q Y, Lin Z X, et al. Effect of integrated traditional Chinese and western medicine therapy for acute hypertensive intracerebral hemorrhage: a meta-analysis [J]. Artif Cells Nanomed Biotechnol, 2017, 45(6): 1-6.
[6] Hawkes M A, Rabinstein A A. Acute hypertensive response in patients with acute intracerebral hemorrhage: a narrative review [J]. Neurology, 2021, 97(7): 316-329.
[7] 刘 岩.内镜微创与开窗血肿清除术在高血压性脑出血手术中的应用[J]. 中国实用医药, 2022, 17(1): 39-41.
[8] Bowman K M, Ahmed A S. Surgical indications and options for hypertensive hemorrhages [J]. Neurol Clin, 2022, 40(2): 337-353.
[9] Dastur C K, Yu W G. Current management of spontaneous intracerebral haemorrhage [J]. Stroke Vasc Neurol, 2017, 2(1): 21-29.
[10] Lo B W Y, Teitelbaum J S. Hyperthermia, cerebral edema, and outcome in intracerebral hemorrhage: too darn hot [J]. Neurology, 2020, 94(16): 687-688.
[11] 吴科学, 达 瓦, 曹旭东. 高原出血性脑卒中血肿吸收时间及治疗决策的分析[J]. 西藏科技, 2016, 274(1): 31-32.
[12] 冯学迅. 神经内镜血肿清除术治疗高血压性脑出血疗效观察[J]. 中国药物与临床, 2022, 22(3): 257-259.
[13] 解 岗. 显微镜下经侧裂岛叶入路治疗高血压性基底节区脑出血21例[J]. 武警医学, 2019, 30(8): 720-722.
[14] Murthy S B, Moradiya Y, Dawson J, et al. Perihematomal edema and functional outcomes in intracerebral hemorrhage: influence of hematoma volume and location [J]. Stroke, 2015, 46(11): 3088-3092.
[15] 赵晓晶, 李群喜, 刘 英, 等. 美国国立卫生院脑卒中量表评分与脑出血患者预后的相关性探讨[J]. 中国临床医生杂志, 2019, 47(6): 712-714.
[16] Han M, Ding S, Zhang Y, et al. Serum copper homeostasis in hypertensive intracerebral hemorrhage and its clinical significance [J]. Biol Trace Elem Res, 2018, 185(1): 56-62.
[17] 丁 毅, 韩和平, 唐 超. 颅内压监测仪联合软通道穿刺引流术治疗高血压脑出血的疗效及对内皮素-1和基质金属蛋白酶-9的影响[J]. 中国医学装备, 2022, 19(1): 107-111.
[18] 黎炳润, 罗赛华, 江庆炎. 硬通道和软通道微创穿刺引流术治疗高血压脑出血的可行性及安全性比较[J]. 慢性病学杂志, 2018, 19(10): 1341-1343,1347.
[19] 冀首鹏, 王颖博, 徐丹阳, 等. 颅内血肿微创穿刺引流术联合rt-PA在老年中等量基底节区脑出血患者中的应用效果[J]. 河南医学研究, 2020, 29(14): 2574-2576.
[20] 曹朝阳, 李 明, 朱新建, 等. 重组组织型纤溶酶原激活药静脉溶栓治疗发病4.5 h内急性脑梗死的疗效和安全性[J]. 武警医学, 2017, 28(7): 653-655.
PDF(983 KB)
